Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 Presentation.

Monypenny J, Milewicz H, Flores-Borja F, Weitsman G, Cheung A, Chowdhury R, Burgoyne T, Arulappu A, Lawler K, Barber PR, Vicencio JM, Keppler M, Wulaningsih W, Davidson SM, Fraternali F, Woodman N, Turmaine M, Gillett C, Franz D, Quezada SA, Futter CE, Von Kriegsheim A, Kolch W, Vojnovic B, Carlton JG, Ng T.

Cell Rep. 2018 Jul 17;24(3):630-641. doi: 10.1016/j.celrep.2018.06.066.

2.

Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface.

Claus J, Patel G, Autore F, Colomba A, Weitsman G, Soliman TN, Roberts S, Zanetti-Domingues LC, Hirsch M, Collu F, George R, Ortiz-Zapater E, Barber PR, Vojnovic B, Yarden Y, Martin-Fernandez ML, Cameron A, Fraternali F, Ng T, Parker PJ.

Elife. 2018 May 1;7. pii: e32271. doi: 10.7554/eLife.32271.

3.

Electrically tunable fluidic lens imaging system for laparoscopic fluorescence-guided surgery.

Volpi D, Tullis IDC, Barber PR, Augustyniak EM, Smart SC, Vallis KA, Vojnovic B.

Biomed Opt Express. 2017 Jun 13;8(7):3232-3247. doi: 10.1364/BOE.8.003232. eCollection 2017 Jul 1.

4.

Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor.

Weitsman G, Mitchell NJ, Evans R, Cheung A, Kalber TL, Bofinger R, Fruhwirth GO, Keppler M, Wright ZVF, Barber PR, Gordon P, de Koning T, Wulaningsih W, Sander K, Vojnovic B, Ameer-Beg S, Lythgoe M, Arnold JN, Årstad E, Festy F, Hailes HC, Tabor AB, Ng T.

Oncogene. 2017 Jun 22;36(25):3618-3628. doi: 10.1038/onc.2016.522. Epub 2017 Feb 6.

5.

RORγt+ Innate Lymphoid Cells Promote Lymph Node Metastasis of Breast Cancers.

Irshad S, Flores-Borja F, Lawler K, Monypenny J, Evans R, Male V, Gordon P, Cheung A, Gazinska P, Noor F, Wong F, Grigoriadis A, Fruhwirth GO, Barber PR, Woodman N, Patel D, Rodriguez-Justo M, Owen J, Martin SG, Pinder SE, Gillett CE, Poland SP, Ameer-Beg S, McCaughan F, Carlin LM, Hasan U, Withers DR, Lane P, Vojnovic B, Quezada SA, Ellis P, Tutt AN, Ng T.

Cancer Res. 2017 Mar 1;77(5):1083-1096. doi: 10.1158/0008-5472.CAN-16-0598. Epub 2017 Jan 12.

6.

Feedback activation of HER3 attenuates response to EGFR inhibitors in colon cancer cells.

Bosch-Vilaró A, Jacobs B, Pomella V, Abbasi Asbagh L, Kirkland R, Michel J, Singh S, Liu X, Kim P, Weitsman G, Barber PR, Vojnovic B, Ng T, Tejpar S.

Oncotarget. 2017 Jan 17;8(3):4277-4288. doi: 10.18632/oncotarget.13834.

7.

HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status.

Weitsman G, Barber PR, Nguyen LK, Lawler K, Patel G, Woodman N, Kelleher MT, Pinder SE, Rowley M, Ellis PA, Purushotham AD, Coolen AC, Kholodenko BN, Vojnovic B, Gillett C, Ng T.

Oncotarget. 2016 Aug 9;7(32):51012-51026. doi: 10.18632/oncotarget.9963.

8.

Correction: Robust Bayesian Fluorescence Lifetime Estimation, Decay Model Selection and Instrument Response Determination for Low-Intensity FLIM Imaging.

Rowley MI, Coolen AC, Vojnovic B, Barber PR.

PLoS One. 2016 Aug 25;11(8):e0162224. doi: 10.1371/journal.pone.0162224. eCollection 2016.

9.

Robust Bayesian Fluorescence Lifetime Estimation, Decay Model Selection and Instrument Response Determination for Low-Intensity FLIM Imaging.

Rowley MI, Coolen AC, Vojnovic B, Barber PR.

PLoS One. 2016 Jun 29;11(6):e0158404. doi: 10.1371/journal.pone.0158404. eCollection 2016. Erratum in: PLoS One. 2016;11(8):e0162224.

10.

A method for accurate spatial registration of PET images and histopathology slices.

Puri T, Chalkidou A, Henley-Smith R, Roy A, Barber PR, Guerrero-Urbano T, Oakley R, Simo R, Jeannon JP, McGurk M, Odell EW, O'Doherty MJ, Marsden PK.

EJNMMI Res. 2015 Dec;5(1):64. doi: 10.1186/s13550-015-0138-7. Epub 2015 Nov 14.

11.

Effect of phosphorylation on EGFR dimer stability probed by single-molecule dynamics and FRET/FLIM.

Coban O, Zanetti-Dominguez LC, Matthews DR, Rolfe DJ, Weitsman G, Barber PR, Barbeau J, Devauges V, Kampmeier F, Winn M, Vojnovic B, Parker PJ, Lidke KA, Lidke DS, Ameer-Beg SM, Martin-Fernandez ML, Ng T.

Biophys J. 2015 Mar 10;108(5):1013-26. doi: 10.1016/j.bpj.2015.01.005.

12.

Imaging tumour heterogeneity of the consequences of a PKCα-substrate interaction in breast cancer patients.

Weitsman G, Lawler K, Kelleher MT, Barrett JE, Barber PR, Shamil E, Festy F, Patel G, Fruhwirth GO, Huang L, Tullis ID, Woodman N, Ofo E, Ameer-Beg SM, Irshad S, Condeelis J, Gillett CE, Ellis PA, Vojnovic B, Coolen AC, Ng T.

Biochem Soc Trans. 2014 Dec;42(6):1498-505. doi: 10.1042/BST20140165. Review.

13.

"Broadbeam" irradiation of mammalian cells using a vertical microbeam facility.

Jeynes JC, Merchant MJ, Barazzuol L, Barry M, Guest D, Palitsin VV, Grime GW, Tullis ID, Barber PR, Vojnovic B, Kirkby KJ.

Radiat Environ Biophys. 2013 Nov;52(4):513-21. doi: 10.1007/s00411-013-0487-4. Epub 2013 Aug 21.

PMID:
23963461
14.

The Gray Institute 'open' high-content, fluorescence lifetime microscopes.

Barber PR, Tullis ID, Pierce GP, Newman RG, Prentice J, Rowley MI, Matthews DR, Ameer-Beg SM, Vojnovic B.

J Microsc. 2013 Aug;251(2):154-67. doi: 10.1111/jmi.12057. Epub 2013 Jun 12.

15.

Influence of soluble or matrix-bound isoforms of vascular endothelial growth factor-A on tumor response to vascular-targeted strategies.

Akerman S, Fisher M, Daniel RA, Lefley D, Reyes-Aldasoro CC, Lunt SJ, Harris S, Bjorndahl M, Williams LJ, Evans H, Barber PR, Prise VE, Vojnovic B, Kanthou C, Tozer GM.

Int J Cancer. 2013 Dec 1;133(11):2563-76. doi: 10.1002/ijc.28281. Epub 2013 Jul 10.

16.

A focused scanning vertical beam for charged particle irradiation of living cells with single counted particles.

Merchant MJ, Jeynes JC, Grime GW, Palitsin V, Tullis ID, Barber PR, Vojnovic B, Webb RP, Kirkby KJ.

Radiat Res. 2012 Sep;178(3):182-90. Epub 2012 Jul 23.

PMID:
22823572
17.

Operable non-small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia.

Mandeville HC, Ng QS, Daley FM, Barber PR, Pierce G, Finch J, Burke M, Bell A, Townsend ER, Kozarski R, Vojnovic B, Hoskin PJ, Goh V.

Radiology. 2012 Aug;264(2):581-9. doi: 10.1148/radiol.12111505. Epub 2012 Jun 14.

PMID:
22700554
18.

A multi-functional imaging approach to high-content protein interaction screening.

Matthews DR, Fruhwirth GO, Weitsman G, Carlin LM, Ofo E, Keppler M, Barber PR, Tullis ID, Vojnovic B, Ng T, Ameer-Beg SM.

PLoS One. 2012;7(4):e33231. doi: 10.1371/journal.pone.0033231. Epub 2012 Apr 10.

19.

In situ biological dose mapping estimates the radiation burden delivered to 'spared' tissue between synchrotron X-ray microbeam radiotherapy tracks.

Rothkamm K, Crosbie JC, Daley F, Bourne S, Barber PR, Vojnovic B, Cann L, Rogers PA.

PLoS One. 2012;7(1):e29853. doi: 10.1371/journal.pone.0029853. Epub 2012 Jan 6.

20.

Use of the mouse aortic ring assay to study angiogenesis.

Baker M, Robinson SD, Lechertier T, Barber PR, Tavora B, D'Amico G, Jones DT, Vojnovic B, Hodivala-Dilke K.

Nat Protoc. 2011 Dec 22;7(1):89-104. doi: 10.1038/nprot.2011.435.

PMID:
22193302
21.

A targeted siRNA screen identifies regulators of Cdc42 activity at the natural killer cell immunological synapse.

Carlin LM, Evans R, Milewicz H, Fernandes L, Matthews DR, Perani M, Levitt J, Keppler MD, Monypenny J, Coolen T, Barber PR, Vojnovic B, Suhling K, Fraternali F, Ameer-Beg S, Parker PJ, Thomas NS, Ng T.

Sci Signal. 2011 Nov 29;4(201):ra81. doi: 10.1126/scisignal.2001729.

22.
23.

The challenges of integrating molecular imaging into the optimization of cancer therapy.

Patel GS, Kiuchi T, Lawler K, Ofo E, Fruhwirth GO, Kelleher M, Shamil E, Zhang R, Selvin PR, Santis G, Spicer J, Woodman N, Gillett CE, Barber PR, Vojnovic B, Kéri G, Schaeffter T, Goh V, O'Doherty MJ, Ellis PA, Ng T.

Integr Biol (Camb). 2011 Jun;3(6):603-31. doi: 10.1039/c0ib00131g. Epub 2011 May 4. Review.

PMID:
21541433
24.

ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.

Cornelissen B, Darbar S, Hernandez R, Kersemans V, Tullis I, Barber PR, Smart S, Vojnovic B, Reilly R, Vallis KA.

J Nucl Med. 2011 May;52(5):776-83. doi: 10.2967/jnumed.110.084392. Epub 2011 Apr 15.

25.

How Förster resonance energy transfer imaging improves the understanding of protein interaction networks in cancer biology.

Fruhwirth GO, Fernandes LP, Weitsman G, Patel G, Kelleher M, Lawler K, Brock A, Poland SP, Matthews DR, Kéri G, Barber PR, Vojnovic B, Ameer-Beg SM, Coolen AC, Fraternali F, Ng T.

Chemphyschem. 2011 Feb 25;12(3):442-61. doi: 10.1002/cphc.201000866. Epub 2011 Feb 15. Review.

PMID:
21328516
26.

Parametric mapping of immunohistochemically stained tissue sections; a method to quantify the colocalization of tumor markers.

Rademakers SE, Rijken PF, Peeters WJ, Nijkamp MM, Barber PR, van der Laak J, van de Kogel AJ, Bussink J, Kaanders JH.

Cell Oncol (Dordr). 2011 Apr;34(2):119-29. doi: 10.1007/s13402-010-0008-2. Epub 2011 Feb 8.

27.

A Bayesian method for single molecule, fluorescence burst analysis.

Barber PR, Ameer-Beg SM, Pathmananthan S, Rowley M, Coolen AC.

Biomed Opt Express. 2010 Oct 12;1(4):1148-1158.

28.

Time-lapse FRET microscopy using fluorescence anisotropy.

Matthews DR, Carlin LM, Ofo E, Barber PR, Vojnovic B, Irving M, Ng T, Ameer-Beg SM.

J Microsc. 2010 Jan;237(1):51-62. doi: 10.1111/j.1365-2818.2009.03301.x.

29.

The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients.

Kelleher MT, Fruhwirth G, Patel G, Ofo E, Festy F, Barber PR, Ameer-Beg SM, Vojnovic B, Gillett C, Coolen A, Kéri G, Ellis PA, Ng T.

Target Oncol. 2009 Sep;4(3):235-52. doi: 10.1007/s11523-009-0116-y. Epub 2009 Sep 16. Review.

30.

Integrating receptor signal inputs that influence small Rho GTPase activation dynamics at the immunological synapse.

Makrogianneli K, Carlin LM, Keppler MD, Matthews DR, Ofo E, Coolen A, Ameer-Beg SM, Barber PR, Vojnovic B, Ng T.

Mol Cell Biol. 2009 Jun;29(11):2997-3006. doi: 10.1128/MCB.01008-08. Epub 2009 Mar 23.

31.

Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumors.

Tozer GM, Akerman S, Cross NA, Barber PR, Björndahl MA, Greco O, Harris S, Hill SA, Honess DJ, Ireson CR, Pettyjohn KL, Prise VE, Reyes-Aldasoro CC, Ruhrberg C, Shima DT, Kanthou C.

Cancer Res. 2008 Apr 1;68(7):2301-11. doi: 10.1158/0008-5472.CAN-07-2011.

32.

Estimation of apparent tumor vascular permeability from multiphoton fluorescence microscopic images of P22 rat sarcomas in vivo.

Reyes-Aldasoro CC, Wilson I, Prise VE, Barber PR, Ameer-Beg M, Vojnovic B, Cunningham VJ, Tozer GM.

Microcirculation. 2008 Jan;15(1):65-79.

PMID:
17952797
33.

Time-correlated single-photon counting fluorescence lifetime confocal imaging of decayed and sound dental structures with a white-light supercontinuum source.

McConnell G, Girkin JM, Ameer-Beg SM, Barber PR, Vojnovic B, Ng T, Banerjee A, Watson TF, Cook RJ.

J Microsc. 2007 Feb;225(Pt 2):126-36.

34.

Correlation of spectral imaging and visual grading for the quantification of thymidylate synthase protein expression in rectal cancer.

Atkin G, Barber PR, Vojnovic B, Daley FM, Glynne-Jones R, Wilson GD.

Hum Pathol. 2005 Dec;36(12):1302-8. Epub 2005 Nov 2.

PMID:
16311124
35.

Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy.

Tozer GM, Ameer-Beg SM, Baker J, Barber PR, Hill SA, Hodgkiss RJ, Locke R, Prise VE, Wilson I, Vojnovic B.

Adv Drug Deliv Rev. 2005 Jan 2;57(1):135-52. Review.

PMID:
15518926
36.

Target validation of cytochrome P450 CYP1B1 in prostate carcinoma with protein expression in associated hyperplastic and premalignant tissue.

Carnell DM, Smith RE, Daley FM, Barber PR, Hoskin PJ, Wilson GD, Murray GI, Everett SA.

Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):500-9.

PMID:
14751521
37.

The vascular targeting agent combretastatin A-4-phosphate induces neutrophil recruitment to endothelial cells in vitro.

Brooks AC, Kanthou C, Cook IH, Tozer GM, Barber PR, Vojnovic B, Nash GB, Parkins CS.

Anticancer Res. 2003 Jul-Aug;23(4):3199-206.

PMID:
12926054
38.

Semi-automated software for the three-dimensional delineation of complex vascular networks.

Barber PR, Vojnovic B, Ameer-Beg SM, Hodgkiss RJ, Tozer GM, Wilson J.

J Microsc. 2003 Jul;211(Pt 1):54-62.

39.

Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability.

Tozer GM, Prise VE, Wilson J, Cemazar M, Shan S, Dewhirst MW, Barber PR, Vojnovic B, Chaplin DJ.

Cancer Res. 2001 Sep 1;61(17):6413-22.

40.

Automated counting of mammalian cell colonies.

Barber PR, Vojnovic B, Kelly J, Mayes CR, Boulton P, Woodcock M, Joiner MC.

Phys Med Biol. 2001 Jan;46(1):63-76.

PMID:
11197679
41.

Infrared-induced photodarkening in Tm-doped fluoride fibers.

Barber PR, Paschotta R, Tropper AC, Hanna DC.

Opt Lett. 1995 Nov 1;20(21):2195. No abstract available.

PMID:
19862295

Supplemental Content

Loading ...
Support Center